By Xavier Fontdegloria
Merck KGaA said Thursday that it expects revenue and revenue growth in 2022 after revenue and revenue growth in the first quarter due to good performance in the life sciences sector.
German pharmaceutical and chemical companies posted after-tax profits of € 884 million ($ 929.5 million) in the first quarter, an increase of 18% from € 748 million registered in the year-ago quarter. .. Analysts expected Merck KGaA to report € 1.05 billion in after-tax profit, according to a consensus forecast provided by FactSet.
Net sales were up 12% to € 5.2 billion, the company said, with all business units driving organic growth. Economists expect sales of € 5.09 billion.
Earnings before interest, taxes, depreciation and temporary items before depreciation, or one of the company’s careful metrics, Ebitda pre increased 7.8% from € 1.51 billion in the previous year to 1.6 billion. It is now 30 million euros.
According to Merck KGaA, net sales in 2022 are expected to be € 21.6 billion to € 22.8 billion and Ebitdapre from € 6.10 to € 6.6 billion to € 7.1 billion, compared to € 19.69 billion in 2021. a billion.
However, the company said the predictions could be more uncertain and are based on the assumption of a short-term and locally restricted blockade in China.
Write to XavierFontdegloria at email@example.com
MerckKGaA1Q After tax PftEUR884M
Source link MerckKGaA1Q After tax PftEUR884M